New online tool that empowers parents to treat child anxiety could expand access to child mental health services
New research from the University of Oxford has revealed that an online programme that empowers parents to apply Cognitive Behavioural Therapy (CBT) principles in their child’s day to day lives is just as effective as traditional talking therapies for child anxiety problems.
New data shows prevalence of Premenstrual Dysphoric Disorder (PMDD)
Around 1.6% of women and girls have symptomatic Premenstrual Dysphoric Disorder (PMDD), according to a new review of global studies.
Next step in plans for Warneford Park
Plans for Warneford Park took a step forward as partners in the project signed a Conditional Option Agreement (COA) and Memorandum of Understanding (MOU), agreeing how they will work together going forward.
Call for more research investment for serious mental illness treatments
More focused research on medication for serious mental illness is needed in the UK according to a leading Oxford Professor.
Launch of innovative new study to tackle mental health inequalities
Learning more about how to tackle mental health inequalities will be the focus of an innovative new study working with diverse people living with psychosis and other long-term physical health conditions. People with psychosis are more likely to also have long-term physical illnesses, with a life expectancy 15-20 years lower than average[1] [2]. In turn, people from black and minority ethnic communities are more likely to experience psychosis but also face greater social disadvantages and poorer access to care.
2023 Highly cited researchers
Clarivate, the global leader in trusted and transformative intelligence has today announced its 2023 highly cited researchers.
Virtual Reality technology to treat agoraphobia approved for use in the NHS
Today, for the first time a virtual reality treatment (VR) has been recommended for use in NHS mental health services.
Evaluation of image analysis technology supporting dementia diagnosis
Health Innovation Oxford and Thames Valley have published a case study on their involvement in the development of a dementia diagnostic called FSL, a software platform which can extract metrics from brain scans.
Celebrating another successful year of biomedical research
Developments and improvements to the treatment and knowledge of conditions including depression, dementia and psychosis were in the spotlight at a recent event in Oxford.
Oxford grandfather takes part in study testing if weight loss drug can help Alzheimer’s disease
An Oxford grandfather taking part in a research trial into whether a new weight loss drug can help Alzheimer’s patients has urged others to consider joining studies.